01 1Olon S.p.A
01 1LENVATINIB MESYLATE FORM C
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-11-26
Pay. Date : 2024-09-30
DMF Number : 37347
Submission : 2022-07-28
Status : Active
Type : II
20
Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LENVATINIB MESYLATE FORM C, with a corresponding US DMF Number 37347.
Remarkably, this DMF maintains an Active status since its submission on July 28, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 26, 2024, and payment made on September 30, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
